Sinecod (citrate butamirate) drops oral for children 5 mg/ml. 20 ml. vial

Description

Sinecod (citrate butamirate) drops oral for children 5 mg/ml. 20 ml. vial

Composition

active ingredient: butamirate citrate;

1 ml (20 drops) of solution contains 5 mg of citrate butamirate;

excipients: sorbitol solution 70% (E 420), glycerin, sodium saccharin, benzoic acid (E 210), vanillin, ethanol 96%, sodium hydroxide 30%, purified water.

Dosage form

Drops oral for children.

Basic physical and chemical properties: a clear solution from colorless to brownish-yellowish.

Pharmacological group

Means used for coughs and colds. Cough suppressants.
Code ATX R05D B13.

Pharmacological properties

Non-opiate antitussive agent with central action. However, the exact mechanism of action is unknown.

The active ingredient of Sinekod is butamirate citrate, which depresses cough and differs in structure and pharmacological action from opium alkaloids. It is believed that this substance acts on the central nervous system. Butamirate citrate leads to a non-specific anticholinergic and bronchospasmolytic effect, which improves respiratory function. Synekod does not entail addiction or dependence.

Butamirate citrate has a wide therapeutic range, so Sinekod is well tolerated at therapeutic doses and is well suited as a cough suppressant in children.

Indications

Sinecod drops is used in the treatment of a non-productive, wasting cough. It is prescribed for the treatment of dry, debilitating cough with whooping cough, cough of smokers and dry cough that occurs with infectious and inflammatory lesions of the respiratory system.
Such use of Sinekod is advisable for suppressing the cough reflex during diagnostic studies (for example, bronchoscopy) and surgical treatment of the respiratory system.

Contraindications

Sinekod is not used for hypersensitivity to butamirate citrate, pulmonary hemorrhage, the first trimester of pregnancy and lactation.
Sinecode in syrup is not used in the treatment of children under three years of age, and in drops – under 2 months.
The drug is used with caution in the therapy of women in the II and III trimesters of pregnancy, as well as in patients who have a history of drug or alcohol dependence, liver disease, epilepsy and brain damage, since the drug contains ethyl alcohol.

Application during pregnancy and lactation

Due to the fact that no studies have been conducted on the effect of Sinekod on fetal development, its use in the therapy of the first trimester of pregnancy is impossible. The use of Sinekod in the II and III trimesters is possible only with a careful balance of benefits and harms from its use.
The appointment of Sinekod during lactation is possible only after refusal to breastfeed, since it is not known whether butamirate citrate is able or not to penetrate into breast milk and what effect it can have on the development of the newborn.

Method of administration and dosage

It is recommended to use Sinecod drops and syrup before meals. Before taking a drop, it is recommended to dissolve it in a small amount of water. The duration of treatment and the dose of the drug is determined by the doctor.
When using drops, children from 2 months to 1 year take 10 drops, from a year to 3 years – 15 drops four times a day. Children over 3 years old, as well as adolescents and adults, should take 25 drops four times a day.

Overdose

When taking Sinekod in high doses, it is possible to develop nausea, vomiting, diarrhea, severe drowsiness, dizziness, lowering blood pressure and loss of consciousness.
In case of an overdose, gastric lavage is carried out, an abundant drink and activated carbon are provided. Also, the patient was shown the appointment of osmotic laxatives and symptomatic treatment.

Side effects

When taking Sinekod, some patients develop fatigue, headaches, dyspeptic disorders, sleep disorders and allergic reactions.